The abstract is read at the publisher; the summary is JClub's.
Llama-derived nanobody nZ6.2 binds Z-DNA with picomolar affinity and selectively captures Z-DNA–bound ADAR1 and ZBP1 without inducing B-to-Z transitions.
- Why it matters: Z-DNA forms transiently at susceptible genomic sites and can trigger innate immune signaling via ZBP1, but progress has been constrained by reliance on the Z22 monoclonal antibody.
- What they did: Llamas were immunized with brominated poly(dG:dC) DNA, yielding nanobodies nZ6, nZ6.2, nZ10, and nZ11; biochemical assays mapped selective Z-DNA recognition and affinity, including picomolar binding by homodimerized nZ6.2.
- The result: nZ6.2 does not induce B-to-Z transitions and selectively co-immunoprecipitates ADAR1 and ZBP1 with Z-DNA, while staining in a human keratinocyte line and patient neutrophils with systemic lupus erythematous overlaps Z22 patterns.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.